HUP9801338A2 - Use of tricyclic carbamate derivatives for inhibition of g-protein function and for treatment of proliferative diseases - Google Patents

Use of tricyclic carbamate derivatives for inhibition of g-protein function and for treatment of proliferative diseases

Info

Publication number
HUP9801338A2
HUP9801338A2 HU9801338A HUP9801338A HUP9801338A2 HU P9801338 A2 HUP9801338 A2 HU P9801338A2 HU 9801338 A HU9801338 A HU 9801338A HU P9801338 A HUP9801338 A HU P9801338A HU P9801338 A2 HUP9801338 A2 HU P9801338A2
Authority
HU
Hungary
Prior art keywords
inhibition
treatment
proliferative diseases
protein function
carbamate derivatives
Prior art date
Application number
HU9801338A
Other languages
Hungarian (hu)
Inventor
W. Robert Bishop
Ronald J. Doll
Alan K. Mallams
F. George Njoroge
Joanne M. Petrin
John J. Piwinski
Stacy W. Remiszewski
Arthur G. Taveras
Ronald L. Wolin
Original Assignee
Schering Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp. filed Critical Schering Corp.
Priority to HU9801338A priority Critical patent/HUP9801338A3/en
Publication of HUP9801338A2 publication Critical patent/HUP9801338A2/en
Publication of HUP9801338A3 publication Critical patent/HUP9801338A3/en

Links

Landscapes

  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

11-Substd.-5H-benzo(5,6)cyclohepta(1,2-b)pyridines of formula (I) are new. R = H or Br; R' = 1-methyl-piperidin-3-yl; 1-methyl-piperidin-4-yl; or pyridin-3-yl-N-oxide.
HU9801338A 1996-03-21 1996-03-21 Use of tricyclic carbamate derivatives for inhibition of g-protein function and for treatment of proliferative diseases HUP9801338A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9801338A HUP9801338A3 (en) 1996-03-21 1996-03-21 Use of tricyclic carbamate derivatives for inhibition of g-protein function and for treatment of proliferative diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9801338A HUP9801338A3 (en) 1996-03-21 1996-03-21 Use of tricyclic carbamate derivatives for inhibition of g-protein function and for treatment of proliferative diseases

Publications (2)

Publication Number Publication Date
HUP9801338A2 true HUP9801338A2 (en) 2000-01-28
HUP9801338A3 HUP9801338A3 (en) 2000-03-28

Family

ID=89996672

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801338A HUP9801338A3 (en) 1996-03-21 1996-03-21 Use of tricyclic carbamate derivatives for inhibition of g-protein function and for treatment of proliferative diseases

Country Status (1)

Country Link
HU (1) HUP9801338A3 (en)

Also Published As

Publication number Publication date
HUP9801338A3 (en) 2000-03-28

Similar Documents

Publication Publication Date Title
SG48750A1 (en) Tricyclic carbonate compounds useful for inhabition of g-protein function for treatment of proliferative diseases
TW350844B (en) Tricyclic amides useful to inhibition of G-protein function and for treatment of proliferative diseases
MX9707192A (en) Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases.
GB9514473D0 (en) Chemical compounds
HK1023119A1 (en) Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
AU2562797A (en) Combination therapy for treatment of erectile dysfunction
IL111257A0 (en) Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
WO2001044247A3 (en) Agents and methods for the treatment of proliferative diseases
HUP9801396A3 (en) 11-piperidylidene-5h-benzo[5,6]cyclohepta[1,2-b]pirydine-derivatives useful for inhibition of g-protein function and for treatment of proliferative diseases, use thereof and pharmaceutical compositions containing these compounds
IL128003A0 (en) Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies
FI971568A (en) Procedure for the treatment of resistant tumors
AU2002213421A1 (en) Condensed pyridoindole derivatives
AU4960297A (en) Bicyclic aryl carboxamides and their therapeutic use
HK1045526A1 (en) Sapogenin derivatives and their use in the treatment of cognitive dysfunction.
DE69819515D1 (en) HYDROXY PROSTAGLAND DERIVATIVES FOR TREATING ERECTILE DYSFUNCTION
MX9706605A (en) Indole derivatives as eaa antagonists.
AU3628395A (en) Benz{g}indazolyl derivatives for the treatment of inflaminflammation
EP0776204A4 (en) Indole alkaloids useful as uv protective and anti-inflammatory agents
AP9801275A0 (en) Use of tricyclic 1,4-dihydro-1,4-dioxo-1H-naphthalene derivatives resulting novel compounds and therapeutical use thereof
DE69726749D1 (en) 5-HETEROATOM ALKYL SUBSTITUTED 3-OXO-PYRIDO (1,2-A) BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS
HU9401833D0 (en) Use of renin inhibitors for the treatment of glaucoma
HUP9801338A2 (en) Use of tricyclic carbamate derivatives for inhibition of g-protein function and for treatment of proliferative diseases
WO2001044235A3 (en) Agents and methods for the treatment of proliferative diseases
IL143181A0 (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
PL329053A1 (en) Novel derivatives of oxazolydine, method of obtaining them and therapeutic agents containing such compounds